I want to describe a clinical picture that comes up more often than you’d expect, because it has a particular pattern that’s recognisable once you’ve seen it a few times. The person in question is doing everything right. They’ve cleaned up their diet — lots of vegetables, particularly the dark leafy ones. Almonds instead of crisps. Dark chocolate as a treat because antioxidants. Maybe a daily green smoothie with spinach and almond milk. They’ve been on this protocol for a year or more, and they feel worse than they did before they started. Diffuse joint pain. Fatigue that doesn’t track with sleep quality. Sometimes urinary urgency or a burning sensation. Sometimes what gets labelled fibromyalgia. The OAT comes back with oxalic acid significantly elevated. And the source is the diet that was supposed to be helping them.
Oxalates are organic acids found in varying concentrations in a wide range of plant foods. They serve a function in the plant — binding calcium and other minerals, deterring insects, regulating internal chemistry. In humans, they’re managed primarily in the gut, where specific bacteria degrade them before they can be absorbed in any significant quantity. When those bacteria are present and functioning, most dietary oxalate is neutralised before it causes problems. When they’re depleted — through antibiotics, dysbiosis, or gut barrier compromise — oxalate absorption increases substantially, and the consequences of that accumulation show up in tissue.
What Oxalates Are and Where They Come From
Oxalic acid is produced through two routes: dietary intake and endogenous synthesis. The body produces oxalate as a metabolic byproduct of several pathways, including the breakdown of vitamin C and the amino acid glycine. In most people, this endogenous production is a minor contributor to total oxalate load compared with dietary intake — but in people with specific genetic variants affecting the glyoxylate pathway, endogenous production can be the dominant source regardless of what they eat.
The dietary sources vary enormously in their oxalate concentration:
Very high (avoid or minimise during oxalate reduction protocols): Spinach · Almonds · Beets and beetroot · Swiss chard · Rhubarb · Dark chocolate and cocoa · Star fruit · Buckwheat · Peanuts and peanut butter
High: Sweet potato · Cashews · Okra · Black tea · Most berries · Kiwi fruit · Leeks
Moderate: Oats · Brown rice · Some legumes · Broccoli · Carrots
Low: Meat · Fish · Eggs · Most dairy · White rice · Cabbage · Cauliflower · Cucumber · Melon · Banana
Important note: Boiling vegetables and discarding the water removes 30–90% of their oxalate content. Steaming and roasting do not. This single cooking change makes many moderate-oxalate vegetables significantly safer for people with elevated OAT findings.
The reason the smoothie is a particular problem is concentration and the raw preparation. A smoothie containing 80g of raw spinach, a handful of almonds, and a tablespoon of cocoa powder might contain as much oxalate as the rest of the day’s food combined — delivered rapidly in liquid form, which increases absorption rate. Presented as a health intervention, consumed daily for months or years, by someone whose gut bacteria can’t handle the load. This is not a theoretical risk. I see the result of it regularly on OAT results.
The Gut Bacteria at the Centre of This
Oxalobacter formigenes is a gut bacterium whose entire metabolic existence is built around degrading oxalate. It uses oxalate as its primary energy source, which means it’s highly efficient at removing it from the gut before it can be absorbed. Research has consistently shown that people colonised with O. formigenes have significantly lower urinary oxalate levels and substantially lower rates of kidney stone formation than those without it.
The problem is that O. formigenes is exquisitely sensitive to antibiotics. A single course of broad-spectrum antibiotics can eliminate it from the gut entirely, and unlike most commensal bacteria, it doesn’t reliably re-establish itself from environmental exposure because it’s not widely present in food or the general environment. Once it’s gone, it tends to stay gone unless actively reintroduced — which currently isn’t straightforward because it’s not available as a commercial probiotic.
Several Lactobacillus and Bifidobacterium species also contribute to oxalate degradation, to a lesser degree. This is clinically significant because it means that broad gut dysbiosis — the kind that shows up on a GI-MAP as depleted commensals — will often correlate with elevated oxalate on the OAT even in the absence of confirmed O. formigenes loss. Restore the microbiome, and oxalate handling often improves alongside it.
One course of broad-spectrum antibiotics can eliminate Oxalobacter formigenes entirely. It doesn’t reliably re-establish itself. The elevated oxalates on someone’s OAT might trace back to a chest infection treated ten years ago.
What Elevated Oxalates Actually Do in the Body
Kidney stones are the most well-known consequence, and they’re real — calcium oxalate is the most common type of kidney stone and directly reflects elevated urinary oxalate excretion. But kidney stones are the end of a long process, and most people with elevated oxalates on the OAT don’t have stones. What they have is a more diffuse picture of tissue deposition and the inflammatory response it provokes.
Oxalate crystals deposit in soft tissue — joints, muscle, the vulvar vestibule, the kidneys, the thyroid, and in some cases the cardiac tissue. The body treats these crystals as foreign material and mounts an inflammatory response around them. This produces joint pain and stiffness that closely mimics fibromyalgia or inflammatory arthritis, often with no elevation in standard inflammatory markers because the inflammation is localised around the crystal deposits rather than systemic. It also produces the unexplained musculoskeletal pain and tenderness that gets labelled as “functional” when a rheumatologist finds nothing on imaging.
Vulvodynia — chronic vulvar pain without an identifiable cause — has a well-documented association with elevated oxalates, and low-oxalate dietary protocols have been used clinically for this presentation for decades, with consistent reported benefit. Yet the majority of women with this diagnosis are never told about the oxalate connection, because it sits outside the gynaecological investigation framework.
The mitochondrial connection is where it gets particularly relevant to the fatigue picture. Oxalate inhibits several enzymes in the Krebs cycle — specifically succinate dehydrogenase and components of the electron transport chain. In practical terms, this means elevated oxalate impairs cellular energy production by the same mechanism that shows up as elevated Krebs cycle acids on the OAT. Someone with both elevated oxalate and elevated Krebs cycle markers may have a compounded mitochondrial problem: the gut dysbiosis is producing metabolic inhibitors (as described in the OAT and mitochondrial function post), and the elevated oxalate is doing its own damage to the same pathway.
The OAT Markers and What They Tell You
The OAT measures three oxalate-related markers: oxalic acid, glycolic acid, and glyceric acid. Each points to a different part of the picture.
Oxalic acid is the primary marker — the direct measure of oxalate load. Elevation can reflect dietary intake, impaired gut degradation, or increased endogenous production. Clinically, this is the number that tells you whether oxalate is worth investigating as a contributing factor.
Glycolic acid elevation alongside oxalic acid points toward the glyoxylate pathway — the metabolic route by which the body produces oxalate endogenously. When glycolic acid is elevated with oxalic acid, it suggests the problem isn’t purely dietary. This pattern is associated with a genetic variant affecting the enzyme alanine-glyoxylate aminotransferase (AGT), which normally converts glyoxylate to glycine rather than allowing it to be oxidised to oxalate. B6 is the cofactor for this enzyme — which is why B6 supplementation is part of the protocol for elevated glycolic acid alongside oxalate.
Glyceric acid elevation with oxalate points toward a different genetic variant affecting hydroxypyruvate reductase. This is rarer, and when present it suggests a primary hyperoxaluria type 2 pattern that warrants further investigation beyond the OAT alone.
In clinical practice, most elevated oxalate findings on functional OAT testing are the straightforward combination of high dietary intake and depleted gut degradation capacity — elevated oxalic acid with normal or mildly elevated glycolic acid, in someone who is eating a lot of high-oxalate foods and whose GI-MAP shows dysbiosis. The interpretation is relatively straightforward, the intervention is clearly defined, and the response to dietary modification plus gut repair is usually measurable on repeat testing.
The B6 Connection Worth Knowing About
B6 (pyridoxine) is the cofactor for the enzyme that diverts glyoxylate away from oxalate production. When B6 is functionally deficient — even if serum levels look acceptable — the glyoxylate pathway shifts toward oxalate production, increasing endogenous synthesis independently of dietary intake. The OAT measures functional B6 status via xanthurenate and kynurenate. If these are elevated alongside elevated oxalic acid, B6 functional deficiency is contributing to the oxalate load, and targeted B6 repletion (typically as pyridoxal-5-phosphate, the active form) is part of the intervention alongside dietary work.
This is the kind of cross-marker interpretation that makes the OAT genuinely useful rather than just a list of numbers. Elevated oxalate alone is one clinical picture. Elevated oxalate with elevated B6 functional deficiency markers and elevated Krebs cycle acids tells a considerably more specific story — and points toward a considerably more targeted protocol.
What the Protocol Actually Looks Like
The approach isn’t blanket elimination of oxalate-containing foods forever — that’s neither practical nor necessary in most cases. The clinical goal is reducing the acute load while restoring the gut’s capacity to handle dietary oxalate appropriately, then reintroducing foods gradually once that capacity is re-established.
In the short term: shift away from the very high-oxalate foods (particularly raw spinach and almonds, which tend to be the biggest contributors in people eating “healthily”), switch to boiling vegetables rather than steaming or eating raw, and take calcium citrate or calcium carbonate with meals — calcium binds oxalate in the gut before it can be absorbed, forming calcium oxalate that passes through rather than being absorbed. This is the most evidence-supported dietary intervention for elevated urinary oxalate outside of frank genetic hyperoxaluria.
The gut repair piece runs in parallel: restoring Lactobacillus species that contribute to oxalate degradation, addressing any pathogens or dysbiosis shown on the GI-MAP that are competing with or crowding out the oxalate-degrading commensals, and supporting gut barrier integrity so that paracellular oxalate absorption (the route by which oxalate crosses a leaky barrier without going through the normal degradation process) is reduced.
If B6 functional deficiency is confirmed, supplementation with P5P alongside dietary modification addresses both the degradation capacity and the endogenous production simultaneously.
The OAT oxalate markers are one of the findings I find most practically useful, partly because the intervention is well-defined and the response is relatively quick to see — urinary oxalate can drop significantly within weeks of dietary modification in people with high dietary intake as the primary driver. But more than that, it’s a finding that explains things for people. The person who has been eating spinach every day for two years and getting progressively more achey, more tired, more convinced they’re developing something serious — finding out that their carefully constructed healthy diet is contributing to the problem is not a small thing. It’s a concrete, testable, addressable answer. Which is what functional testing should produce.